BMCRX
Price
$27.31
Change
-$0.47 (-1.69%)
Updated
Feb 4 closing price
Net Assets
1.59B
GFACX
Price
$65.94
Change
-$0.63 (-0.95%)
Updated
Feb 4 closing price
Net Assets
335.97B
Interact to see
Advertisement

BMCRX vs GFACX

Header iconBMCRX vs GFACX Comparison
Open Charts BMCRX vs GFACXBanner chart's image
BlackRock Advantage Large Cap Gr R
Price$27.31
Change-$0.47 (-1.69%)
VolumeN/A
Net Assets1.59B
American Funds Growth Fund of Amer C
Price$65.94
Change-$0.63 (-0.95%)
VolumeN/A
Net Assets335.97B
BMCRX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
BMCRX vs. GFACX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMCRX is a Buy and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 336B vs. BMCRX (1.59B). BMCRX (0.00) and GFACX (0.00) have matching dividends . BMCRX was incepted earlier than GFACX: BMCRX (16 years) vs GFACX (25 years). BMCRX (1.37) and GFACX (1.35) have similar cost to investors . BMCRX is a more actively managed with annual turnover of: 149.00 vs. GFACX (32.00). BMCRX has a lower initial minimum investment than GFACX: BMCRX (100) vs GFACX (250). BMCRX annual gain was more profitable for investors over the last year : 9.67 vs. GFACX (0.14). BMCRX return over 5 years is better than : 23.68 vs. GFACX (4.02).
BMCRXGFACXBMCRX / GFACX
Total Expense Ratio1.121.3583%
Annual Report Gross Expense Ratio1.371.35101%
Fund Existence16 years25 years-
Gain YTD-1.907-1.085176%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.59B336B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.670.147,145%
Returns for 3 years50.9036.22141%
Returns for 5 years23.684.02590%
Returns for 10 years162.0793.69173%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNSBF2.91N/A
N/A
Hansa Medical AB
RTBBF25.61N/A
N/A
RATHBONES GROUP PLC.
SPEV0.01N/A
N/A
Shorepower Technologies Inc.
SEOVF0.11-0.01
-4.43%
SERNOVA BIOTHERAPEUTICS INC.
STGPF2.69-0.18
-6.26%
Scentre Group